C-Met: A Potential Therapeutic Target for Hepatocellular Carcinoma

Drug discoveries & therapeutics - Japan
doi 10.5582/ddt.2011.v5.1.2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Related search

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2018English

Role of C-Met in the Progression of Human Oral Squamous Cell Carcinoma and Its Potential as a Therapeutic Target

Oncology Reports
MedicineCancer ResearchOncology
2017English

PI3Kδ Is a New Therapeutic Target in Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2018English

Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Quantitative Phosphoproteomic Analysis Identifies the Potential Therapeutic Target EphA2 for Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Cells

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2020English

A Selective C-Met and TRKS Inhibitor Indo5 Suppresses Hepatocellular Carcinoma Growth

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Integrative Bioinformatics Analysis Identifies ROBO1 as a Potential Therapeutic Target Modified by miR-218 in Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy